A federal magistrate judge has recommended that a federal court dismiss a whistleblower lawsuit brought by two former Solvay reps, who contended the drugmaker concocted an illegal scheme to promote a drug for off-label use and, consequently, caused the federal government's Medicaid program to overpay by millions of dollars.
The drug in question was Marinol , which was originally approve...
